{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:27:03Z","timestamp":1789694823681,"version":"4.0.1"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1R21NS139178-01"],"award-info":[{"award-number":["1R21NS139178-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008451","name":"SUNY | Binghamton University","doi-asserted-by":"publisher","award":["TAE 1182867"],"award-info":[{"award-number":["TAE 1182867"]}],"id":[{"id":"10.13039\/100008451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008451","name":"SUNY | Binghamton University","doi-asserted-by":"publisher","award":["ADLG258"],"award-info":[{"award-number":["ADLG258"]}],"id":[{"id":"10.13039\/100008451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Eng"],"DOI":"10.1038\/s44172-025-00581-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T15:06:13Z","timestamp":1768057573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Microengineering of the capillary interface of midbrain dopaminergic neurons to study Parkinson\u2019s disease vascular alterations"],"prefix":"10.1038","volume":"5","author":[{"given":"Anika","family":"Alim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoongyeong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungwoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4044-0785","authenticated-orcid":false,"given":"Jungwook","family":"Paek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"581_CR1","first-page":"1","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 1\u201321 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"581_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"G. B. D","year":"2019","unstructured":"G. B. D 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"key":"581_CR3","first-page":"1","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras, C. et al. Prevalence of Parkinson\u2019s disease across North America. npj Parkinson\u2019s. Dis. 4, 1\u20137 (2018).","journal-title":"npj Parkinson\u2019s. Dis."},{"key":"581_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"581_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.870100309","volume":"10","author":"RKB Pearce","year":"1995","unstructured":"Pearce, R. K. B., Hawkes, C. H. & Daniel, S. E. The anterior olfactory nucleus in Parkinson\u2019s disease. Mov. Disord. 10, 283\u2013287 (1995).","journal-title":"Mov. Disord."},{"key":"581_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.26082","volume":"30","author":"PA LeWitt","year":"2015","unstructured":"LeWitt, P. A. Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics. Mov. Disord. 30, 64\u201372 (2015).","journal-title":"Mov. Disord."},{"key":"581_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/mds.1099","volume":"16","author":"LM Shulman","year":"2001","unstructured":"Shulman, L. M., Taback, R. L., Bean, J. & Weiner, W. J. Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease. Mov. Disord. 16, 507\u2013510 (2001).","journal-title":"Mov. Disord."},{"key":"581_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122, 1437\u20131448 (1999).","journal-title":"Brain"},{"key":"581_CR9","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/glia.23839","volume":"68","author":"I Morales","year":"2020","unstructured":"Morales, I. et al. Neuroglial transmitophagy and Parkinson\u2019s disease. Glia 68, 2277\u20132299 (2020).","journal-title":"Glia"},{"key":"581_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258\u2013262 (2018).","journal-title":"Nature"},{"key":"581_CR11","unstructured":"Kouli. et al. 2018)."},{"key":"581_CR12","doi-asserted-by":"publisher","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","volume":"2","author":"DW Dickson","year":"2012","unstructured":"Dickson, D. W. Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect. Med 2, a009258 (2012).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"581_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","volume":"16","author":"J Brettschneider","year":"2015","unstructured":"Brettschneider, J., Tredici, K. D., Lee, V. M.-Y. & Trojanowski, J. Q. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat. Rev. Neurosci. 16, 109\u2013120 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"581_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J. Exp. Med 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med"},{"key":"581_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker, M. & Walker, L. C. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat. Neurosci. 21, 1341\u20131349 (2018).","journal-title":"Nat. Neurosci."},{"key":"581_CR16","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. -Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"581_CR18","doi-asserted-by":"crossref","unstructured":"Wakabayashi, K., Tanji, K., Mori, F. & Takahashi, H. The Lewy body in Parkinson\u2019s disease: Molecules implicated in the formation and degradation of \u03b1-synuclein aggregates. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1789.2007.00803.x (2007).","DOI":"10.1111\/j.1440-1789.2007.00803.x"},{"key":"581_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat. Neurosci. 22, 1248\u20131257 (2019).","journal-title":"Nat. Neurosci."},{"key":"581_CR20","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.febslet.2015.10.023","volume":"589","author":"E Luna","year":"2015","unstructured":"Luna, E. & Luk, K. C. Bent out of shape: \u03b1-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson\u2019s disease. FEBS Lett. 589, 3749\u20133759 (2015).","journal-title":"FEBS Lett."},{"key":"581_CR21","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR22","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner, S. B. et al. Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. 112, E5308\u2013E5317 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR23","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino, A. N. et al. Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. 111, 10732\u201310737 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-021-01131-8","volume":"9","author":"N Ferreira","year":"2021","unstructured":"Ferreira, N. et al. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. acta neuropathol. commun. 9, 31 (2021).","journal-title":"acta neuropathol. commun."},{"key":"581_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body\u2013like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat. Med 14, 504\u2013506 (2008).","journal-title":"Nat. Med"},{"key":"581_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li, J.-Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med 14, 501\u2013503 (2008).","journal-title":"Nat. Med"},{"key":"581_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","volume":"23","author":"J Guan","year":"2013","unstructured":"Guan, J. et al. Vascular degeneration in Parkinson\u2019s disease. Brain Pathol. 23, 154\u2013164 (2013).","journal-title":"Brain Pathol."},{"key":"581_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26066-5","volume":"12","author":"I Pediaditakis","year":"2021","unstructured":"Pediaditakis, I. et al. Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption. Nat. Commun. 12, 5907 (2021).","journal-title":"Nat. Commun."},{"key":"581_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas, R. et al. Blood\u2013brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann. Neurol. 57, 176\u2013179 (2005).","journal-title":"Ann. Neurol."},{"key":"581_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/mds.25066","volume":"27","author":"I Rektor","year":"2012","unstructured":"Rektor, I. et al. Impairment of brain vessels may contribute to mortality in patients with Parkinson\u2019s disease. Mov. Disord. 27, 1169\u20131172 (2012).","journal-title":"Mov. Disord."},{"key":"581_CR31","doi-asserted-by":"crossref","unstructured":"Paul, G. & Elabi, O. F. Microvascular Changes in Parkinson\u2019s Disease- Focus on the Neurovascular Unit. Front. Aging Neurosci. 14, 853372 (2022).","DOI":"10.3389\/fnagi.2022.853372"},{"key":"581_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0006-8993(71)90439-2","volume":"25","author":"MR Issidorides","year":"1971","unstructured":"Issidorides, M. R. Neuronal vascular relationships in the zona compacta of normal and Parkinsonian substantia nigra. Brain Res. 25, 289\u2013299 (1971).","journal-title":"Brain Res."},{"key":"581_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/JPD-140454","volume":"5","author":"P Yang","year":"2015","unstructured":"Yang, P. et al. String vessel formation is increased in the brain of Parkinson disease. J. Parkinson\u2019s. Dis. 5, 821\u2013836 (2015).","journal-title":"J. Parkinson\u2019s. Dis."},{"key":"581_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/JAD-2010-100219","volume":"21","author":"WR Brown","year":"2010","unstructured":"Brown, W. R. A review of string vessels or collapsed, empty basement membrane tubes. J. Alzheimer\u2019s. Dis. 21, 725\u2013739 (2010).","journal-title":"J. Alzheimer\u2019s. Dis."},{"key":"581_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2020.02.019","volume":"73","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Vascular, flow and perfusion abnormalities in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 73, 8\u201313 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"581_CR36","doi-asserted-by":"crossref","unstructured":"Al-Bachari, S., Naish, J. H., Parker, G. J. M., Emsley, H. C. A. & Parkes, L. M. Blood\u2013brain barrier leakage is increased in Parkinson\u2019s disease. Front. Physiol. 11, 593026 (2020).","DOI":"10.3389\/fphys.2020.593026"},{"key":"581_CR37","doi-asserted-by":"crossref","unstructured":"Lagan\u00e0, M. M. et al. Multimodal evaluation of neurovascular functionality in early Parkinson\u2019s Disease. Front. Neurol. 11, 831 (2020).","DOI":"10.3389\/fneur.2020.00831"},{"key":"581_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s004010000195","volume":"100","author":"E Farkas","year":"2000","unstructured":"Farkas, E., De Jong, G. I., de Vos, R. A., Jansen Steur, E. N. & Luiten, P. G. Pathological features of cerebral cortical capillaries are doubled in Alzheimer\u2019s disease and Parkinson\u2019s disease. Acta Neuropathol. 100, 395\u2013402 (2000).","journal-title":"Acta Neuropathol."},{"key":"581_CR39","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","volume":"101","author":"I Rite","year":"2007","unstructured":"Rite, I., Machado, A., Cano, J. & Venero, J. L. Blood\u2013brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J. Neurochem. 101, 1567\u20131582 (2007).","journal-title":"J. Neurochem."},{"key":"581_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80889-8","volume":"11","author":"O Elabi","year":"2021","unstructured":"Elabi, O. et al. Human \u03b1-synuclein overexpression in a mouse model of Parkinson\u2019s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci. Rep. 11, 1120 (2021).","journal-title":"Sci. Rep."},{"key":"581_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux, B. A., Bonnet, A. M., Agid, Y. & Hirsch, E. C. Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease. Lancet 353, 981\u2013982 (1999).","journal-title":"Lancet"},{"key":"581_CR42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s12035-022-03119-4","volume":"60","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Endothelial LRP1-ICD accelerates cognition-associated alpha-synuclein pathology and neurodegeneration through PARP1 activation in a mouse model of Parkinson\u2019s disease. Mol. Neurobiol. 60, 979\u20131003 (2023).","journal-title":"Mol. Neurobiol."},{"key":"581_CR43","doi-asserted-by":"crossref","unstructured":"Vandendriessche, C. et al. The spreading and effects of human recombinant \u03b1-synuclein preformed fibrils in the cerebrospinal fluid of mice. eNeuro. https:\/\/www.eneuro.org\/content\/11\/3\/ENEURO.0024-23.2024 (2024).","DOI":"10.1523\/ENEURO.0024-23.2024"},{"key":"581_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/glia.24109","volume":"70","author":"G Lan","year":"2022","unstructured":"Lan, G. et al. Astrocytic VEGFA: an essential mediator in blood\u2013brain-barrier disruption in Parkinson\u2019s disease. Glia 70, 337\u2013353 (2022).","journal-title":"Glia"},{"key":"581_CR45","doi-asserted-by":"publisher","first-page":"106298","DOI":"10.1016\/j.nbd.2023.106298","volume":"187","author":"K Lau","year":"2023","unstructured":"Lau, K., Porschen, L. T., Richter, F. & Gericke, B. Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61). Neurobiol. Dis. 187, 106298 (2023).","journal-title":"Neurobiol. Dis."},{"key":"581_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00441-017-2730-9","volume":"373","author":"A Recasens","year":"2018","unstructured":"Recasens, A., Ulusoy, A., Kahle, P. J., Di Monte, D. A. & Dehay, B. In vivo models of alpha-synuclein transmission and propagation. Cell Tissue Res 373, 183\u2013193 (2018).","journal-title":"Cell Tissue Res"},{"key":"581_CR47","first-page":"658083","volume":"2011","author":"JA Potashkin","year":"2010","unstructured":"Potashkin, J. A., Blume, S. R. & Runkle, N. K. Limitations of animal models of Parkinson\u2019s disease. Parkinsons Dis. 2011, 658083 (2010).","journal-title":"Parkinsons Dis."},{"key":"581_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","volume":"285","author":"W-L Kuan","year":"2016","unstructured":"Kuan, W.-L. et al. \u03b1-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function. Exp. Neurol. 285, 72\u201381 (2016).","journal-title":"Exp. Neurol."},{"key":"581_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka, K. et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat. Commun. 10, 5816 (2019).","journal-title":"Nat. Commun."},{"key":"581_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijbiomac.2022.12.134","volume":"229","author":"H Hourfar","year":"2023","unstructured":"Hourfar, H. et al. The impact of \u03b1-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells. Int. J. Biol. Macromol. 229, 305\u2013320 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"581_CR51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1177\/0271678X17740793","volume":"38","author":"WA Banks","year":"2018","unstructured":"Banks, W. A., Kovac, A. & Morofuji, Y. Neurovascular unit crosstalk: pericytes and astrocytes modify cytokine secretion patterns of brain endothelial cells. J. Cereb. Blood Flow. Metab. 38, 1104\u20131118 (2018).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"581_CR52","doi-asserted-by":"publisher","first-page":"45663","DOI":"10.1021\/acsomega.4c06546","volume":"9","author":"M Khalid Iqbal","year":"2024","unstructured":"Khalid Iqbal, M. et al. The impact of the blood\u2013brain barrier and its dysfunction in Parkinson\u2019s disease: contributions to pathogenesis and progression. ACS Omega 9, 45663\u201345672 (2024).","journal-title":"ACS Omega"},{"key":"581_CR53","doi-asserted-by":"crossref","unstructured":"Bogale, T. A. et al. Alpha-synuclein in the regulation of brain endothelial and perivascular cells: gaps and future perspectives. Front. Immunol. 12, 611761 (2021).","DOI":"10.3389\/fimmu.2021.611761"},{"key":"581_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03442-1","volume":"11","author":"A Dravid","year":"2021","unstructured":"Dravid, A., Raos, B., Svirskis, D. & O\u2019Carroll, S. J. Optimised techniques for high-throughput screening of differentiated SH-SY5Y cells and application for neurite outgrowth assays. Sci. Rep. 11, 23935 (2021).","journal-title":"Sci. Rep."},{"key":"581_CR55","doi-asserted-by":"publisher","unstructured":"Shipley, M. M., Mangold, C. A. & Szpara, M. L. Differentiation of the SH-SY5Y human neuroblastoma cell line. J. Vis. Exp. 53193. https:\/\/doi.org\/10.3791\/53193 (2016).","DOI":"10.3791\/53193"},{"key":"581_CR56","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1083\/jcb.200805132","volume":"183","author":"I Nikonenko","year":"2008","unstructured":"Nikonenko, I. et al. PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J. Cell Biol. 183, 1115\u20131127 (2008).","journal-title":"J. Cell Biol."},{"key":"581_CR57","doi-asserted-by":"publisher","first-page":"16150","DOI":"10.1074\/jbc.M117.782490","volume":"292","author":"Q Wu","year":"2017","unstructured":"Wu, Q., Sun, M., Bernard, L. P. & Zhang, H. Postsynaptic density 95 (PSD-95) serine 561 phosphorylation regulates a conformational switch and bidirectional dendritic spine structural plasticity. J. Biol. Chem. 292, 16150\u201316160 (2017).","journal-title":"J. Biol. Chem."},{"key":"581_CR58","first-page":"445","volume":"21","author":"F Thibaut","year":"1995","unstructured":"Thibaut, F., Vaugeois, J. M. & Petit, M. The dopamine transporter: characterization and physiopathologic implications]. Encephale 21, 445\u2013451 (1995).","journal-title":"Encephale"},{"key":"581_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2018.11.004","volume":"122","author":"KG Mulvihill","year":"2019","unstructured":"Mulvihill, K. G. Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters. Neurochem. Int. 122, 94\u2013105 (2019).","journal-title":"Neurochem. Int."},{"key":"581_CR60","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7, 452\u2013464 (2005).","journal-title":"Neuro Oncol."},{"key":"581_CR61","doi-asserted-by":"publisher","first-page":"109633","DOI":"10.1016\/j.biopha.2019.109633","volume":"121","author":"Q Liu","year":"2020","unstructured":"Liu, Q., Yang, Y. & Fan, X. Microvascular pericytes in brain-associated vascular disease. Biomed. Pharmacother. 121, 109633 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"581_CR62","doi-asserted-by":"crossref","unstructured":"Beard, E., Lengacher, S., Dias, S., Magistretti, P. J. & Finsterwald, C. Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives. Front. Physiol. 12, 825816 (2022).","DOI":"10.3389\/fphys.2021.825816"},{"key":"581_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01628-9","volume":"8","author":"A Verkhratsky","year":"2023","unstructured":"Verkhratsky, A. et al. Astrocytes in human central nervous system diseases: a frontier for new therapies. Sig Transduct. Target Ther. 8, 1\u201337 (2023).","journal-title":"Sig Transduct. Target Ther."},{"key":"581_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 1\u201316 (2023).","journal-title":"Cell Death Dis."},{"key":"581_CR65","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.neuint.2024.105760","volume":"177","author":"S Negi","year":"2024","unstructured":"Negi, S., Khurana, N. & Duggal, N. The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson\u2019s disease. Neurochem. Int. 177, 105760 (2024).","journal-title":"Neurochem. Int."},{"key":"581_CR66","doi-asserted-by":"publisher","first-page":"6137521","DOI":"10.1155\/2020\/6137521","volume":"2020","author":"J He","year":"2020","unstructured":"He, J., Zhu, G., Wang, G. & Zhang, F. Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration. Oxid. Med. Cell. Longev. 2020, 6137521 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"581_CR67","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu, D. M. et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J. Mol. Sci. 23, 5938 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"581_CR68","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti, S. & Bisaglia, M. Oxidative stress and neuroinflammation in parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants 12, 955 (2023).","journal-title":"Antioxidants"},{"key":"581_CR69","doi-asserted-by":"publisher","first-page":"716","DOI":"10.14336\/AD.2017.1018","volume":"9","author":"FD Lazzari","year":"2018","unstructured":"Lazzari, F. D., Bubacco, L., Whitworth, A. J. & Bisaglia, M. Superoxide radical dismutation as new therapeutic strategy in Parkinson\u2019s disease. Aging Dis. 9, 716\u2013728 (2018).","journal-title":"Aging Dis."},{"key":"581_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/antiox9010052","volume":"9","author":"F De Lazzari","year":"2020","unstructured":"De Lazzari, F., Sandrelli, F., Whitworth, A. J. & Bisaglia, M. Antioxidant therapy in Parkinson\u2019s disease: insights from Drosophila melanogaster. Antioxidants 9, 52 (2020).","journal-title":"Antioxidants"},{"key":"581_CR71","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/antiox9070597","volume":"9","author":"K-H Chang","year":"2020","unstructured":"Chang, K.-H. & Chen, C.-M. The role of oxidative stress in Parkinson\u2019s disease. Antioxidants 9, 597 (2020).","journal-title":"Antioxidants"},{"key":"581_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"581_CR73","doi-asserted-by":"publisher","first-page":"17497","DOI":"10.1074\/jbc.RA120.013428","volume":"295","author":"SJ Guiney","year":"2020","unstructured":"Guiney, S. J. et al. Fibrillar \u03b1-synuclein toxicity depends on functional lysosomes. J. Biol. Chem. 295, 17497\u201317513 (2020).","journal-title":"J. Biol. Chem."},{"key":"581_CR74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2021.06.010","volume":"89","author":"JW Howe","year":"2021","unstructured":"Howe, J. W. et al. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein. Parkinsonism Relat. Disord. 89, 41\u201347 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"581_CR75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron 103, 627\u2013641.e7 (2019).","journal-title":"Neuron"},{"key":"581_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23682-z","volume":"12","author":"B Tanudjojo","year":"2021","unstructured":"Tanudjojo, B. et al. Phenotypic manifestation of \u03b1-synuclein strains derived from Parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons. Nat. Commun. 12, 3817 (2021).","journal-title":"Nat. Commun."},{"key":"581_CR77","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbapap.2018.09.012","volume":"1867","author":"EI O\u2019Leary","year":"2019","unstructured":"O\u2019Leary, E. I. & Lee, J. C. Interplay between \u03b1-synuclein amyloid formation and membrane structure. Biochim. et. Biophys. Acta (BBA) - Proteins Proteom. 1867, 483\u2013491 (2019).","journal-title":"Biochim. et. Biophys. Acta (BBA) - Proteins Proteom."},{"key":"581_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion, C. et al. Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 11, 229\u2013234 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"581_CR79","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"581_CR80","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier, A.-L. et al. The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc. Natl. Acad. Sci. 117, 4971\u20134982 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR81","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts, W. et al. \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340\u2013344 (2015).","journal-title":"Nature"},{"key":"581_CR82","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.bpj.2020.01.022","volume":"118","author":"AN Shrivastava","year":"2020","unstructured":"Shrivastava, A. N. et al. Differential membrane binding and seeding of distinct \u03b1-synuclein fibrillar polymorphs. Biophys. J. 118, 1301\u20131320 (2020).","journal-title":"Biophys. J."},{"key":"581_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0859-3","volume":"7","author":"NL Rey","year":"2019","unstructured":"Rey, N. L. et al. \u03b1-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathol. Commun. 7, 221 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"581_CR84","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3390\/ijms21093301","volume":"21","author":"A Mori","year":"2020","unstructured":"Mori, A., Imai, Y. & Hattori, N. Lipids: key players that modulate?-Synuclein toxicity and neurodegeneration in Parkinson\u2019s disease. Int. J. Mol. Sci. 21, 3301 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"581_CR85","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo, N. et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol. Med 17, 1107\u20131118 (2011).","journal-title":"Mol. Med"},{"key":"581_CR86","doi-asserted-by":"publisher","first-page":"14","DOI":"10.52601\/bpr.2022.210033","volume":"8","author":"H Long","year":"2022","unstructured":"Long, H., Zeng, S. & Li, D. Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases. Biophys. Rep. 8, 14\u201328 (2022).","journal-title":"Biophys. Rep."},{"key":"581_CR87","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1523\/JNEUROSCI.0060-19.2019","volume":"39","author":"Q Wu","year":"2019","unstructured":"Wu, Q. et al. \u03b1-Synuclein (\u03b1Syn) preformed fibrils induce endogenous \u03b1Syn aggregation, compromise synaptic activity and enhance synapse loss in cultured excitatory hippocampal neurons. J. Neurosci. 39, 5080\u20135094 (2019).","journal-title":"J. Neurosci."},{"key":"581_CR88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5607\/en23007","volume":"32","author":"BJ Kim","year":"2023","unstructured":"Kim, B. J., Noh, H. R., Jeon, H. & Park, S. M. Monitoring \u03b1-synuclein aggregation Induced by Preformed \u03b1-synuclein fibrils in an in vitro model system. Exp. Neurobiol. 32, 147\u2013156 (2023).","journal-title":"Exp. Neurobiol."},{"key":"581_CR89","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci. Transl. Med. 4, 121ra20\u2013121ra20 (2012).","journal-title":"Sci. Transl. Med."},{"key":"581_CR90","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1172\/JCI35314","volume":"119","author":"L Chen","year":"2009","unstructured":"Chen, L. et al. Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J. Clin. Invest 119, 3257\u20133265 (2009).","journal-title":"J. Clin. Invest"},{"key":"581_CR91","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"581_CR92","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","volume":"25","author":"WW Smith","year":"2005","unstructured":"Smith, W. W. et al. Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 25, 5544\u20135552 (2005).","journal-title":"J. Neurosci."},{"key":"581_CR93","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez, R. G. et al. A role for \u03b1-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22, 3090\u20133099 (2002).","journal-title":"J. Neurosci."},{"key":"581_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34555-4","volume":"13","author":"M Jin","year":"2022","unstructured":"Jin, M. et al. DOPAnization of tyrosine in \u03b1-synuclein by tyrosine hydroxylase leads to the formation of oligomers. Nat. Commun. 13, 6880 (2022).","journal-title":"Nat. Commun."},{"key":"581_CR95","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/187152712800792910","volume":"11","author":"AP Feve","year":"2012","unstructured":"Feve, A. P. Current status of tyrosine hydroxylase in management of Parkinson\u2019s disease. CNS Neurol. Disord. Drug Targets 11, 450\u2013455 (2012).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"581_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00333-8","volume":"8","author":"A Gopinath","year":"2022","unstructured":"Gopinath, A. et al. DAT and TH expression marks human Parkinson\u2019s disease in peripheral immune cells. npj Parkinsons Dis. 8, 1\u201314 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"581_CR97","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00702-022-02488-3","volume":"129","author":"W-D Rausch","year":"2022","unstructured":"Rausch, W.-D., Wang, F. & Radad, K. From the tyrosine hydroxylase hypothesis of Parkinson\u2019s disease to modern strategies: a short historical overview. J. Neural Transm. 129, 487\u2013495 (2022).","journal-title":"J. Neural Transm."},{"key":"581_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14415","volume":"21","author":"R Cacciaglia","year":"2025","unstructured":"Cacciaglia, R. et al. Soluble A\u03b2 pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer\u2019s continuum: evidence across two independent cohorts. Alzheimers Dement. 21, e14415 (2025).","journal-title":"Alzheimers Dement."},{"key":"581_CR99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson\u2019s disease. J. Parkinson\u2019s. Dis. 3, 461\u2013491 (2013).","journal-title":"J. Parkinson\u2019s. Dis."},{"key":"581_CR100","doi-asserted-by":"publisher","first-page":"14465","DOI":"10.1523\/JNEUROSCI.2246-12.2012","volume":"32","author":"AC Crist\u00f3v\u00e3o","year":"2012","unstructured":"Crist\u00f3v\u00e3o, A. C. et al. NADPH oxidase 1 mediates \u03b1-synucleinopathy in Parkinson\u2019s disease. J. Neurosci. 32, 14465\u201314477 (2012).","journal-title":"J. Neurosci."},{"key":"581_CR101","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P. & Malik, A. B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20, 1126\u20131167 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"581_CR102","doi-asserted-by":"publisher","first-page":"105280","DOI":"10.1016\/j.phrs.2020.105280","volume":"162","author":"L Teixeira-Santos","year":"2020","unstructured":"Teixeira-Santos, L., Albino-Teixeira, A. & Pinho, D. Neuroinflammation, oxidative stress and their interplay in neuropathic pain: focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies. Pharmacol. Res. 162, 105280 (2020).","journal-title":"Pharmacol. Res."},{"key":"581_CR103","doi-asserted-by":"crossref","unstructured":"Shih, R.-H., Wang, C.-Y. & Yang, C.-M. NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 8, 77 (2015).","DOI":"10.3389\/fnmol.2015.00077"},{"key":"581_CR104","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"SS Singh","year":"2020","unstructured":"Singh, S. S. et al. NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotox. Res 37, 491\u2013507 (2020).","journal-title":"Neurotox. Res"},{"key":"581_CR105","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1111\/ejn.15242","volume":"54","author":"M Dolatshahi","year":"2021","unstructured":"Dolatshahi, M., Ranjbar Hameghavandi, M. H., Sabahi, M. & Rostamkhani, S. Nuclear factor-kappa B (NF-\u03baB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration. Eur. J. Neurosci. 54, 4101\u20134123 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"581_CR106","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey, M. G. & Goldberg, M. S. Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510\u2013518 (2010).","journal-title":"Neurobiol. Dis."},{"key":"581_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102942","volume":"24","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer\u2019s disease pathology. iScience 24, 102942 (2021).","journal-title":"iScience"},{"key":"581_CR108","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?  Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol."},{"key":"581_CR109","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/cdd.2015.79","volume":"22","author":"A-L Mahul-Mellier","year":"2015","unstructured":"Mahul-Mellier, A.-L. et al. Fibril growth and seeding capacity play key roles in \u03b1-synuclein-mediated apoptotic cell death. Cell Death Differ. 22, 2107\u20132122 (2015).","journal-title":"Cell Death Differ."},{"key":"581_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00583-0","volume":"9","author":"N Ito","year":"2023","unstructured":"Ito, N. et al. Extracellular high molecular weight \u03b1-synuclein oligomers induce cell death by disrupting the plasma membrane. npj Parkinsons Dis. 9, 1\u201310 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"581_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. M. The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol. Neurodegener. 12, 10 (2017).","journal-title":"Mol. Neurodegener."},{"key":"581_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01059-1","volume":"16","author":"D P\u00e9rez-Acu\u00f1a","year":"2023","unstructured":"P\u00e9rez-Acu\u00f1a, D., Shin, S. J., Rhee, K. H., Kim, S. J. & Lee, S.-J. -Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis. Mol. Brain 16, 72 (2023).","journal-title":"Mol. Brain"},{"key":"581_CR113","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41420-023-01790-7","volume":"10","author":"A D\u2019Aloia","year":"2024","unstructured":"D\u2019Aloia, A. et al. A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line. Cell Death Discov. 10, 24 (2024).","journal-title":"Cell Death Discov."},{"key":"581_CR114","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira, S. A. & Romero-Ramos, M. Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front. Cell Neurosci. 12, 247 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"581_CR115","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","volume":"3","author":"H-J Lee","year":"2010","unstructured":"Lee, H.-J., Kim, C. & Lee, S.-J. Alpha-synuclein stimulation of astrocytes. Oxid. Med Cell Longev. 3, 283\u2013287 (2010).","journal-title":"Oxid. Med Cell Longev."},{"key":"581_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39038-8","volume":"14","author":"A de Rus Jacquet","year":"2023","unstructured":"de Rus Jacquet, A. et al. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease. Nat. Commun. 14, 3651 (2023).","journal-title":"Nat. Commun."},{"key":"581_CR117","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","volume":"111","author":"PM Carvey","year":"2009","unstructured":"Carvey, P. M., Hendey, B. & Monahan, A. J. The blood\u2013brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem. 111, 291\u2013314 (2009).","journal-title":"J. Neurochem."},{"key":"581_CR118","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1523\/JNEUROSCI.0944-06.2006","volume":"26","author":"JE Westin","year":"2006","unstructured":"Westin, J. E. et al. Endothelial proliferation and increased blood\u2013brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-l-alanine-induced dyskinesia. J. Neurosci. 26, 9448\u20139461 (2006).","journal-title":"J. Neurosci."},{"key":"581_CR119","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","volume":"96","author":"M Carta","year":"2006","unstructured":"Carta, M. et al. Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. J. Neurochem. 96, 1718\u20131727 (2006).","journal-title":"J. Neurochem."},{"key":"581_CR120","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1177\/0271678X19880161","volume":"40","author":"DN Edwards","year":"2020","unstructured":"Edwards, D. N. et al. Integrin \u03b15\u03b21 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke. J. Cereb. Blood Flow. Metab. 40, 1695\u20131708 (2020).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"581_CR121","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","volume":"111","author":"EA Winkler","year":"2014","unstructured":"Winkler, E. A. et al. Blood\u2013spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl. Acad. Sci. 111, E1035\u2013E1042 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"581_CR122","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2016.06.002","volume":"94","author":"T Padel","year":"2016","unstructured":"Padel, T. et al. Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson\u2019s disease. Neurobiol. Dis. 94, 95\u2013105 (2016).","journal-title":"Neurobiol. Dis."},{"key":"581_CR123","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.1021\/acsnano.9b00686","volume":"13","author":"J Paek","year":"2019","unstructured":"Paek, J. et al. Microphysiological engineering of self-assembled and perfusable microvascular beds for the production of vascularized three-dimensional human microtissues. ACS Nano 13, 7627\u20137643 (2019).","journal-title":"ACS Nano"},{"key":"581_CR124","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui, T. M., Wiesolek, H. L. & Sumagin, R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J. Leukoc. Biol. 108, 787\u2013799 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"581_CR125","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","volume":"26","author":"M Giannotta","year":"2013","unstructured":"Giannotta, M., Trani, M. & Dejana, E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev. Cell 26, 441\u2013454 (2013).","journal-title":"Dev. Cell"},{"key":"581_CR126","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1096\/fj.201802003R","volume":"33","author":"R Singh Angom","year":"2019","unstructured":"Singh Angom, R. et al. VEGF receptor-1 modulates amyloid \u03b2 1-42 oligomer-induced senescence in brain endothelial cells. FASEB J. 33, 4626\u20134637 (2019).","journal-title":"FASEB J."},{"key":"581_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-017-0050-9","volume":"14","author":"TB Terrell-Hall","year":"2017","unstructured":"Terrell-Hall, T. B., Ammer, A. G., Griffith, J. I. G. & Lockman, P. R. Permeability across a novel microfluidic blood-tumor barrier model. Fluids Barriers CNS 14, 3 (2017).","journal-title":"Fluids Barriers CNS"},{"key":"581_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07416-0","volume":"7","author":"S Bang","year":"2017","unstructured":"Bang, S. et al. A low permeability microfluidic blood-brain barrier platform with direct contact between perfusable vascular network and astrocytes. Sci. Rep. 7, 8083 (2017).","journal-title":"Sci. Rep."},{"key":"581_CR129","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0006-8993(99)02471-3","volume":"858","author":"H Akiyama","year":"2000","unstructured":"Akiyama, H. et al. Blood-brain barrier formation of grafted human umbilical vein endothelial cells in athymic mouse brain. Brain Res. 858, 172\u2013176 (2000).","journal-title":"Brain Res."},{"key":"581_CR130","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/STROKEAHA.111.000719","volume":"44","author":"C-C Wu","year":"2013","unstructured":"Wu, C.-C. et al. Human umbilical vein endothelial cells protect against hypoxic-ischemic damage in neonatal brain via stromal cell-derived factor 1\/C-X-C chemokine receptor type 4. Stroke 44, 1402\u20131409 (2013).","journal-title":"Stroke"},{"key":"581_CR131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B","volume":"19","author":"Y Hayashi","year":"1997","unstructured":"Hayashi, Y. et al. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 19, 13\u201326 (1997).","journal-title":"Glia"},{"key":"581_CR132","doi-asserted-by":"crossref","unstructured":"Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475\u2013480 (2018).","DOI":"10.1038\/nature25739"},{"key":"581_CR133","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.cell.2021.04.003","volume":"184","author":"N Dani","year":"2021","unstructured":"Dani, N. et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell 184, 3056\u20133074.e21 (2021).","journal-title":"Cell"},{"key":"581_CR134","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-022-04521-7","volume":"603","author":"FJ Garcia","year":"2022","unstructured":"Garcia, F. J. et al. Single-cell dissection of the human brain vasculature. Nature 603, 893\u2013899 (2022).","journal-title":"Nature"},{"key":"581_CR135","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/0271678X211068528","volume":"42","author":"SK Bonney","year":"2022","unstructured":"Bonney, S. K., Sullivan, L. T., Cherry, T. J., Daneman, R. & Shih, A. Y. Distinct features of brain perivascular fibroblasts and mural cells revealed by in vivo two-photon imaging. J. Cereb. Blood Flow. Metab. 42, 966\u2013978 (2022).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"581_CR136","doi-asserted-by":"crossref","unstructured":"Jones, H. E. et al. Meningeal origins and dynamics of perivascular fibroblast development on the mouse cerebral vasculature. Development 150, dev201805 (2023).","DOI":"10.1242\/dev.201805"},{"key":"581_CR137","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1523\/JNEUROSCI.2524-13.2013","volume":"33","author":"C Soderblom","year":"2013","unstructured":"Soderblom, C. et al. Perivascular Fibroblasts Form the Fibrotic Scar after Contusive Spinal Cord Injury. J. Neurosci. 33, 13882\u201313887 (2013).","journal-title":"J. Neurosci."},{"key":"581_CR138","doi-asserted-by":"crossref","unstructured":"Sosa, M. J., Shih, A. Y. & Bonney, S. K. The elusive brain perivascular fibroblast: a potential role in vascular stability and homeostasis. Front. Cardiovasc. Med. 10, 1283434 (2023).","DOI":"10.3389\/fcvm.2023.1283434"},{"key":"581_CR139","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-021-00525-w","volume":"23","author":"CE Dorrier","year":"2022","unstructured":"Dorrier, C. E., Jones, H. E., Pintari\u0107, L., Siegenthaler, J. A. & Daneman, R. Emerging roles for CNS fibroblasts in health, injury and disease. Nat. Rev. Neurosci. 23, 23\u201334 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"581_CR140","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38, 1285\u20131285 (1988).","journal-title":"Neurology"},{"key":"581_CR141","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","volume":"22","author":"PM Carvey","year":"2005","unstructured":"Carvey, P. M. et al. 6-Hydroxydopamine-induced alterations in blood\u2013brain barrier permeability. Eur. J. Neurosci. 22, 1158\u20131168 (2005).","journal-title":"Eur. J. Neurosci."},{"key":"581_CR142","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W. et al. Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease.  FASEB J. 19, 533\u2013542 (2005).","journal-title":"FASEB J."},{"key":"581_CR143","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mvr.2019.03.005","volume":"124","author":"S Dohgu","year":"2019","unstructured":"Dohgu, S. et al. Monomeric \u03b1-synuclein induces blood\u2013brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro. Microvasc. Res. 124, 61\u201366 (2019).","journal-title":"Microvasc. Res."},{"key":"581_CR144","doi-asserted-by":"crossref","unstructured":"Brown, L. S. et al. Pericytes and neurovascular function in the healthy and diseased brain. Front. Cell. Neurosci. 13, 282 (2019).","DOI":"10.3389\/fncel.2019.00282"},{"key":"581_CR145","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney, M. D., Ayyadurai, S. & Zlokovic, B. V. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat. Neurosci. 19, 771\u2013783 (2016).","journal-title":"Nat. Neurosci."},{"key":"581_CR146","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.jin2311203","volume":"23","author":"O Harackiewicz","year":"2024","unstructured":"Harackiewicz, O. & Grembecka, B. The role of microglia and astrocytes in the pathomechanism of neuroinflammation in Parkinson\u2019s disease\u2014focus on alpha-synuclein. JIN 23, 203 (2024).","journal-title":"JIN"},{"key":"581_CR147","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00068-019-01288-x","volume":"47","author":"C S\u00f6nnerqvist","year":"2021","unstructured":"S\u00f6nnerqvist, C., Brus, O. & Olivecrona, M. Validation of the scandinavian guidelines for initial management of minor and moderate head trauma in children. Eur. J. Trauma Emerg. Surg. 47, 1163\u20131173 (2021).","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"581_CR148","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00702-004-0256-2","volume":"112","author":"C Barcia","year":"2005","unstructured":"Barcia, C. et al. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian. J. Neural Transm. 112, 1237\u20131248 (2005).","journal-title":"J. Neural Transm."},{"key":"581_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02218-8","volume":"18","author":"OF Elabi","year":"2021","unstructured":"Elabi, O. F., Cunha, J. P. M. C. M., Gaceb, A., Fex, M. & Paul, G. High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease. J. Neuroinflamm. 18, 175 (2021).","journal-title":"J. Neuroinflamm."},{"key":"581_CR150","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653\u2013660 (2003).","journal-title":"Nat. Med."},{"key":"581_CR151","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/187152807780077273","volume":"6","author":"A Chetta","year":"2007","unstructured":"Chetta, A., Zanini, A., Torre, O. & Olivieri, D. Vascular remodelling and angiogenesis in asthma: morphological aspects and pharmacological modulation. Inflamm. Allergy Drug Targets 6, 41\u201345 (2007).","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"581_CR152","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.3390\/ijms231810962","volume":"23","author":"D La Mendola","year":"2022","unstructured":"La Mendola, D., Trincavelli, M. L. & Martini, C. Angiogenesis in disease. Int. J. Mol. Sci. 23, 10962 (2022).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Communications Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44172-025-00581-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44172-025-00581-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44172-025-00581-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:04:23Z","timestamp":1770642263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44172-025-00581-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":152,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1038\/s44172-025-00581-5","relation":{},"ISSN":["2731-3395"],"issn-type":[{"value":"2731-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}